Pfizer Inc.

NYSE: PFE · Real-Time Price · USD
25.07
-0.04 (-0.16%)
At close: Aug 15, 2025, 9:57 AM

Pfizer Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
63.63B 59.55B 100.33B 81.29B
Cost of Revenue
21.78B 29.21B 38.24B 34.41B
Gross Profit
41.85B 30.34B 62.09B 46.88B
Operating Income
16.48B 5.29B 37.55B 20.79B
Interest Income
545M 1.62B 251M 36M
Pretax Income
8.02B 1.06B 34.73B 24.31B
Net Income
8.02B 2.13B 31.36B 22.15B
Selling & General & Admin
14.63B 14.47B 13.12B 12.25B
Research & Development
10.74B 10.58B 11.43B 13.83B
Other Expenses
n/a n/a n/a n/a
Operating Expenses
25.36B 25.05B 24.54B 26.08B
Interest Expense
3.09B 2.21B 1.24B 1.29B
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
47.14B 54.26B 62.78B 60.49B
Income Tax Expense
-28M -1.11B 3.33B 1.85B
Shares Outstanding (Basic)
5.66B 5.64B 5.61B 5.6B
Shares Outstanding (Diluted)
5.7B 5.71B 5.73B 5.71B
EPS (Basic)
1.42 0.38 5.59 3.95
EPS (Diluted)
1.41 0.37 5.47 3.88
EBITDA
18.13B 9.56B 41.03B 30.79B
EBIT
11.11B 3.27B 35.97B 25.6B
Depreciation & Amortization
7.01B 6.29B 5.06B 5.19B